April 16 (Reuters) - Nanologica AB (publ) NICA.ST:
Q1 ADJUSTED EPS SEK -0.12
Q1 SALES SEK 10.75 MILLION
OPERATING LOSS FOR Q1 AMOUNTS TO SEK 9.2 MILLION
WE ARE CURRENTLY EXPERIENCING STRONG DEMAND, ESPECIALLY FOR PRODUCT THAT MANUFACTURERS OF GLP-1 ANALOGUES TRADITIONALLY BUY
WE LACK SUFFICIENT VOLUMES OF STOCKS OF THAT PRODUCT TYPE FOR DEMAND WE ARE NOW SEEING
IT IS LIKELY THAT SALES WILL VARY FROM QUARTER TO QUARTER
EXPECT STRONG SALES GROWTH IN THE SECOND HALF OF THE YEAR
Source text: ID:nMFNWd8YQ
Further company coverage: NICA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))